ClinConnect ClinConnect Logo
Search / Trial NCT06848478

Level Up! (The Combined and Independent Effects of Exercise Training and Dietary Enhancement on Cardiometabolic Health in Adolescents with Obesity)

Launched by ARKANSAS CHILDREN'S HOSPITAL RESEARCH INSTITUTE · Feb 24, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Exercise Obesity Diet Cardiometabolic

ClinConnect Summary

The "Level Up!" trial is looking to understand how exercise and healthy eating can improve the health of teenagers who are dealing with obesity. Researchers want to find out if regular exercise, a diet rich in fruits and vegetables, or a combination of both can help improve heart and metabolic health in adolescents. Participants will be divided into four groups: one will receive standard care, another will get exercise coaching and follow a 12-week exercise program, a third will focus on dietary changes with weekly coaching to eat more fruits and vegetables, and the last group will do both exercise and diet changes together.

To join the study, participants need to be between 13 to 17 years old, enrolled in a weight management program, and have specific weight criteria. During the 12 weeks, they will visit the study center three times to provide samples, answer questions about their health, and undergo various health assessments, including fitness tests and body scans. This study is not yet recruiting, but it aims to provide important insights into how lifestyle changes can benefit teenagers struggling with obesity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female aged 13 to 17 years.
  • Newly enrolled in a weight management program.
  • Excessive weight: Class I obesity I (≥95% percentile to \< 120% of the 95th percentile), class II Obesity (≥120 to \<140% of the 95th percentile, or BMI ≥35 to \< 40 g/m2).
  • Less than 60 min/day of moderate to vigorous physical activity.
  • Fruit intake ≤ 1.5 cup equivalent per day.
  • Vegetable intake ≤ 1.5 cup equivalent per day.
  • Medical release.
  • Exclusion Criteria:
  • Type 2 diabetes mellitus.
  • Asthma that requires daily use of inhalers to keep symptoms under control.
  • Asthma that requires the use of rescue inhalers (e.g., albuterol) \>2 days per week
  • Exercise-induced asthma.
  • Autism spectrum disorder (e.g., Autistic disorder, Rett disorder, Asperger disorder, childhood disintegrative disorder, pervasive developmental disorder not otherwise specified (PDD-NOS).
  • Epilepsy.
  • Cancer.
  • Chronic kidney disease.
  • Hormonal disease (e.g., hypothyroidism and growth hormone deficiency).
  • Autoimmune diseases (e.g., lupus, thyroiditis, juvenile idiopathic arthritis).
  • Bleeding disorders (e.g., hemophilia).
  • Chronic infections (e.g., HIV, hepatitis B, hepatitis C).
  • Other pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
  • Pregnancy.
  • Dislike of \> 1 study product assessed at the initial visit.
  • Parent/child refusal to have blood drawn.
  • Refusal to authorize study investigators to access data from the clinical records.

About Arkansas Children's Hospital Research Institute

The Arkansas Children's Hospital Research Institute (ACHRI) is a leading pediatric research organization dedicated to advancing child health through innovative scientific inquiry and clinical trials. As an integral part of Arkansas Children's, ACHRI focuses on a wide range of pediatric conditions, aiming to translate research findings into effective therapies and interventions. With a commitment to collaboration, ACHRI partners with academic institutions, healthcare providers, and industry leaders to enhance the understanding of childhood diseases and improve patient outcomes. Their research initiatives are guided by a patient-centered approach, ensuring that the needs and well-being of children remain at the forefront of their efforts.

Locations

Little Rock, Arkansas, United States

Little Rock, Arkansas, United States

Patients applied

0 patients applied

Trial Officials

Elisabet Borsheim, Ph.D

Principal Investigator

Arkansas Children's Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported